Evaluating the Impact of a Technologically-Enhanced Personal Coaching Program on Hemoglobin A1c in Type 2 Diabetics
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/27/2019 |
| Start Date: | August 5, 2018 |
| End Date: | July 1, 2019 |
Evaluation of the Effects of a Technologically-Enhanced Personal Coaching Program on Hemoglobin A1c in Type 2 Diabetics
Participants diagnosed with Type 2 diabetes receive personal coaching from a Certified
Diabetic Educator (CDE) over a six-month period. The coaching program is enhanced using an
mobile application and care management platform.
Diabetic Educator (CDE) over a six-month period. The coaching program is enhanced using an
mobile application and care management platform.
Participants diagnosed with Type 2 diabetes receive personal coaching from a Certified
Diabetic Educator (CDE) over a six-month period. The coaching program is enhanced by
integrating a participant-facing mobile application with the coaching platform. Blood glucose
test results automatically populate the coaching platform, providing the CDE with information
that may better support their coaching efforts.
The participants complete Diabetes Self Management Education (DSME) learning modules for the
first 7-12 weeks. Following completion of the modules, the coach continues to provide support
to the participant until the 24 weeks after the participant's enrollment.
Diabetic Educator (CDE) over a six-month period. The coaching program is enhanced by
integrating a participant-facing mobile application with the coaching platform. Blood glucose
test results automatically populate the coaching platform, providing the CDE with information
that may better support their coaching efforts.
The participants complete Diabetes Self Management Education (DSME) learning modules for the
first 7-12 weeks. Following completion of the modules, the coach continues to provide support
to the participant until the 24 weeks after the participant's enrollment.
Inclusion Criteria:
- Lives in the United States
- Speaks and understands English
- Has a Type 2 diabetes mellitus diagnosis
- Has a LifeScan Verio Flex blood glucose meter, which is connected to OneTouch Reveal ®
app
- Has a verified A1c ≥ 8%
- Willing to participate in coaching program
Exclusion Criteria:
- Uses a continuous glucose monitoring device
- Currently pregnant
- Unable to make lifestyle behavioral changes due to a cognitive or physical disability
- Has end stage renal disease (ESRD) diagnosis
- Is not able to read or understand English
We found this trial at
1
site
San Francisco, California 94110
Principal Investigator: Kristin Neland, BSN, MPH
Phone: 512-694-7104
Click here to add this to my saved trials
